304 related articles for article (PubMed ID: 33130397)
21. RBM10, a New Regulator of p53.
Jung JH; Lee H; Zeng SX; Lu H
Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
[TBL] [Abstract][Full Text] [Related]
22. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
23. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma.
Chang J; Zhang Y; Zhou T; Qiao Q; Shan J; Chen Y; Jiang W; Wang Y; Liu S; Wang Y; Yu Y; Li C; Li X
J Exp Clin Cancer Res; 2024 Apr; 43(1):104. PubMed ID: 38576051
[TBL] [Abstract][Full Text] [Related]
24. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
[TBL] [Abstract][Full Text] [Related]
25. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.
Nanjo S; Wu W; Karachaliou N; Blakely CM; Suzuki J; Chou YT; Ali SM; Kerr DL; Olivas VR; Shue J; Rotow J; Mayekar MK; Haderk F; Chatterjee N; Urisman A; Yeo JC; Skanderup AJ; Tan AC; Tam WL; Arrieta O; Hosomichi K; Nishiyama A; Yano S; Kirichok Y; Tan DS; Rosell R; Okimoto RA; Bivona TG
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35579943
[TBL] [Abstract][Full Text] [Related]
27. Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA.
Sutherland LC; Thibault P; Durand M; Lapointe E; Knee JM; Beauvais A; Kalatskaya I; Hunt SC; Loiselle JJ; Roy JG; Tessier SJ; Ybazeta G; Stein L; Kothary R; Klinck R; Chabot B
BMC Mol Biol; 2017 Jul; 18(1):19. PubMed ID: 28728573
[TBL] [Abstract][Full Text] [Related]
28. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA circABCC4 regulates lung adenocarcinoma progression via miR-3186-3p/TNRC6B axis.
Liu M; Wang P; Sui X; Ding F; Liu L; Gao Z; Cheng Z
J Cell Biochem; 2020 Oct; 121(10):4226-4238. PubMed ID: 31960988
[TBL] [Abstract][Full Text] [Related]
30. LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing.
Chen QW; Cai QQ; Yang Y; Dong S; Liu YY; Chen ZY; Kang CL; Qi B; Dong YW; Wu W; Zhuang LP; Shen YH; Meng ZQ; Wu XZ
Clin Transl Med; 2023 Jan; 13(1):e1129. PubMed ID: 36650118
[TBL] [Abstract][Full Text] [Related]
31. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
32. Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma.
Rao W; Yang L; Dai N; Zhang L; Liu J; Yang B; Li M; Shan J; Wang Q; Wang D
Clin Transl Oncol; 2023 Jun; 25(6):1767-1778. PubMed ID: 36739576
[TBL] [Abstract][Full Text] [Related]
33. RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
Loiselle JJ; Roy JG; Sutherland LC
PLoS One; 2017; 12(6):e0180258. PubMed ID: 28662214
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
35. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
36. Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing.
Ma Z; Chen H; Xia Z; You J; Han C; Wang S; Xia W; Bai Y; Liu T; Xu L; Zhou G; Xu Y; Yin R
J Exp Clin Cancer Res; 2023 Jul; 42(1):169. PubMed ID: 37461053
[TBL] [Abstract][Full Text] [Related]
37. DDX17 modulates the expression and alternative splicing of genes involved in apoptosis and proliferation in lung adenocarcinoma cells.
He C; Zhang G; Lu Y; Zhou J; Ren Z
PeerJ; 2022; 10():e13895. PubMed ID: 36164607
[TBL] [Abstract][Full Text] [Related]
38. Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma.
Wu Q; Feng L; Wang Y; Mao Y; Di X; Zhang K; Cheng S; Xiao T
Signal Transduct Target Ther; 2022 Aug; 7(1):270. PubMed ID: 35989380
[TBL] [Abstract][Full Text] [Related]
39. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
40. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD).
Wu L; Liu Q; Ruan X; Luan X; Zhong Y; Liu J; Yan J; Li X
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
